Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes
Clinical trial NCT01984606 · WITHDRAWN
Trial details
- NCT number
- NCT01984606
- Sponsor
- Boehringer Ingelheim
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2017-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.